NCT00559273 - A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis | Biotech Hunter

Enrollment

307

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Renal Anemia, Chronic

Interventions

DRUG

Methoxy polyethylene glycol-epoetin beta

1.2 mcg/kg SC monthly, starting dose

DRUG

Darbepoetin alfa

0.45 mcg/kg SC weekly or 0.75 mcg/kg every 2 weeks, starting dose

Trial Locations (76)

100

Taipei

407

Taichung

1071

Budapest

2250

Gosford

2500

Esztergom

3000

Hatvan

3052

Parkville

3073

Reservoir

3186

Clayton

5011

Adelaide

6500

Baja

7390

Szigetvár

8800

Roeselare

9300

Aalst

10400

Bangkok

10700

Bangkok

12120

Pathum Thani

13353

Berlin

22100

Como

23900

Lecco

26900

Lodi

27100

Pavia

28046

Madrid

28922

Madrid

30000

Nakhon Ratchasima

30174

Mestre

34362

Haifa

38222

Volos

41009

Seville

41013

Seville

41100

Modena

44281

Kfar Saba

46005

Cahors

46017

Valencia

49100

Petah Tikva

53127

Bonn

54636

Thessaloniki

63000

Clermont-Ferrand

66424

Homburg/saar

68100

Alexandroupoli

69437

Lyon

74076

Heilbronn

75651

Paris

87042

Limoges

117036

Moscow

125101

Moscow

129110

Moscow

191015

Saint Petersburg

195067

Saint Petersburg

197089

Saint Petersburg

197110

Saint Petersburg

410053

Saratov

T6G 2B7

Edmonton

N6A 5A5

London

M4N 3M5

Toronto

H1T 2M4

Montreal

06002

Nice

41 110

Larissa

Unknown

Hong Kong

Seoul

Bangkok

80-211

Gdansk

40-027

Katowice

31-501

Krakow

90-153

Lodz

26-610

Radom

35-055

Rzeszów

98-200

Sieradz

70-111

Szczecin

02-006

Warsaw

50-417

Wroclaw

120-752

Seoul

133-792

Seoul

08025

Barcelona

08907

Barcelona

07014

Palma de Mallorca

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY